Trade Summary

4 days ago, Malek David I, serving as Dir at Braveheart Bio, Inc. (BRVE), purchased 4,166 shares at $18.00 per share, for a total transaction value of $74,988.00. Following this transaction, Malek David I now holds 533,845 shares of BRVE.

This purchase represents a 0.79% increase in Malek David I's stake in the company.

The trade was executed on Friday, August 7, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 4:31 PM ET, meaning the disclosure happened on the same day as the trade.

Braveheart Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.